Consistent with this finding, bioinformatic analysis of TCGA-LIHC data also showed that Naa20 expression levels in tumors from HCC patients (n = 374) were significantly higher than those in normal tissues (n = 50; Fig. 1b). This evidence concerns the gene NAA20 and hepatocellular carcinoma.